Skip to main content

TuHURA Biosciences, Inc.

HURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001498382

No open-market purchases or sales by TuHURA Biosciences, Inc. insiders were filed in the last 90 days; 89 institutions reported holding it in 13F filings for Q2 2026, worth $21.0M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding TuHURA Biosciences, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of HURA: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders2428+4
Shares2.27M2.78M+507.7K (+22.3%)
Value$3.95M$6.31M+$2.36M (+59.7%)

New holders (8)

Institutions that held TuHURA Biosciences, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to HURA in Q2 2021
InstitutionSharesValue% of portfolio
BlackRock Inc.75,704$172.0K0.00%
Golden State Equity Partners71,320$162.0K0.06%
Pura Vida Investments, LLC28,180$64.0K0.00%
Two Sigma Advisers, LP10,114$23.0K0.00%
Tower Research Capital LLC (TRC)3,198$7.00K0.00%
Wealth Quarterback LLC2,000$5.00K0.00%
Financial Enhancement Group LLC1,250$3.00K0.00%
Bank of America Corp13$00.00%

Sold out (4)

Institutions that held TuHURA Biosciences, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of HURA in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Renaissance Technologies LLC46,500$81.0K
Two Sigma Securities, LLC12,092$21.0K
Farmers National Bank11,250$19.6K
Sowell Financial Services LLC8,274$10.0K